Search for the latest updates on Argo
News
RedHill Biopharma acquires Phase II oncology drug Globes Online - 17 minutes
Mesupron, which targets gastrointestinal and solid tumor cancers, has been licensed from Wilex.
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment